Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Vaccines|April 24, 2014
Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvantsThomas W Dubensky, David B Kanne, Meredith L Leong
Infection and Immunity|June 17, 2009
Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in miceMeredith L Leong, Johannes Hampl, Weiqun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2004
Listeria-based cancer vaccines that segregate immunogenicity from toxicityDirk G Brockstedt, Martin A Giedlin, Meredith L Leong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Activation of immature hepatic NK cells as immunotherapy for liver metastatic diseaseKeith S Bahjat, Rodney A Prell, Heather E Allen, et al.
Infection and Immunity|June 11, 2008
Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strainsPeter Lauer, Bill Hanson, Edward E Lemmens, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Recombinant <i>Listeria</i> promotes tumor rejection by CD8<sup>+</sup> T cell-dependent remodeling of the tumor microenvironmentWeiwen Deng, Victor Lira, Thomas E Hudson, et al.
Infection and Immunity|June 26, 2019
A Potent and Effective Suicidal <i>Listeria</i> Vaccine PlatformWilliam G Hanson, Erin L Benanti, Edward E Lemmens, et al.
Cancer Immunology Research|February 24, 2018
TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic TumorsBrian J Francica, Ali Ghasemzadeh, Anthony L Desbien, et al.
Cancer Research|January 21, 2006
Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenesKiyoshi Yoshimura, Ajay Jain, Heather E Allen, et al.
Cell Reports|May 3, 2018
STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis InfectionErik Van Dis, Kimberly M Sogi, Chris S Rae, et al.
Pageof 2